Treatment for Friedreich’s ataxia should not be reimbursed by HSE, drug group recommends

Treatment for Friedreich’s ataxia should not be reimbursed by HSE, drug group recommends

The Irish Times logoThe Irish Times

Disease causes progressive damage to the nervous system with those affected having shorter life expectancy